# Acutaas Chemicals Ltd (ACUTAAS)

NSE equity · series EQ · Biotechnology · Small Cap

Data as of **2026-10-01**. End-of-day data derived from NSE bhavcopy. Historical prices are adjusted for splits and bonuses.

## Latest session

| Field | Value |
| --- | --- |
| Close | ₹3,196.5 |
| Change | -82.9 (-2.53%) |
| Open / High / Low | 3,249 / 3,282.7 / 3,152.3 |
| Volume | 3,81,484 |
| Delivery | 50.99% |
| VWAP | 3,189.56 |
| 52-week high / low | 3,694.8 / 1,381.5 |
| From 52-week high | -13.49% |
| Market cap | ₹13,536.57 crore |

## Returns

| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD |
| --- | --- | --- | --- | --- | --- | --- | --- |
| -2.66% | +0.70% | -10.40% | +37.07% | +131.38% | +4046.99% | +3959.56% | +87.49% |

## Last 10 sessions

| Date | Open | High | Low | Close | Volume | Delivery % |
| --- | --- | --- | --- | --- | --- | --- |
| 2026-10-01 | 3,249 | 3,282.7 | 3,152.3 | 3,196.5 | 3,81,484 | 50.99 |
| 2026-09-30 | 3,334.1 | 3,344 | 3,255 | 3,279.4 | 3,49,433 | 53.25 |
| 2026-09-29 | 3,290 | 3,340 | 3,202.1 | 3,304.1 | 9,99,485 | 47.54 |
| 2026-09-28 | 3,272.5 | 3,273.1 | 3,184.3 | 3,214.4 | 2,02,322 | 48.69 |
| 2026-09-25 | 3,294.9 | 3,311.4 | 3,232 | 3,272.5 | 1,53,473 | 47.46 |
| 2026-09-24 | 3,232 | 3,366.6 | 3,232 | 3,283.7 | 3,21,801 | 40.72 |
| 2026-09-23 | 3,209.1 | 3,276 | 3,167 | 3,265.2 | 4,48,482 | 42.92 |
| 2026-09-22 | 3,450 | 3,450 | 3,200 | 3,213.7 | 4,82,993 | 52.54 |
| 2026-09-21 | 3,460 | 3,509.9 | 3,399 | 3,425.7 | 3,27,627 | 42.5 |
| 2026-09-18 | 3,334 | 3,462 | 3,302.5 | 3,440.3 | 5,21,496 | 50.75 |

## Corporate actions

| Ex-date | Type | Detail |
| --- | --- | --- |
| 2025-04-25 | SUBDIVISION | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share |

## More data

- JSON with one year of daily history: https://bhavcopy.live/agents/stocks/ACUTAAS.json
- Full history (compact app format, see /llms.txt): https://bhavcopy.live/market_data/equity-details/ACUTAAS.json
- Market overview: https://bhavcopy.live/agents/market.md

_For information only. Not investment advice. Verify with the exchange before acting on this data._
